ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) stock surged +0.30%, trading at $26.10 on NASDAQ, up from the previous close of $26.02. The stock opened at $26.00, fluctuating between $26.00 and $26.13 in the recent session.
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Employees | 217 |
Beta | 0.18 |
Sales or Revenue | $130.19M |
5Y Sales Change% | 1.115% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Pharmaceuticals |
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep